ECDC published a Rapid Risk Assessment for the EU/EEA of the mpox epidemic caused by monkeypox virus clade I in affected African countries [1] on 16 August 2024 and an epidemiological update on Monday 26 August [2]. The levels of risk assessed in the risk assessment and the recommendations remain unchanged. Competent Authorities for Substances of Human Origin (SoHO) and SoHO professionals should consider the additional recommendations presented below.
In addition, ECDC monitors mpox trends through routine indicator-based surveillance in the EU/EEA and event-based surveillance globally. An epidemiological update on mpox due to MPXV clade I can also be found in the latest Communicable Diseases Threat report [3] and below.
